Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Blog In Health

New HIV pill on track for FDA approval

By Tim Sandle
Posted May 16, 2012 in Health
Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group. The US regulator is set to make a final decision on the Quad – a combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate – by the end of August 2012.
The FDA’s Antiviral Drugs Advisory Committee voted 13 to 1 to approve it for the treatment of HIV-1 infection in treatment-naïve adults.
For further details, see InPharma

More about HIV, Aids, Fda